Surgical Endoscopy

, Volume 25, Issue 5, pp 1699–1700

Right colectomy: is it a safe and feasible totally laparoscopic approach with transvaginal specimen extraction



  1. 1.
    Kuhry E, Schwenk W, Gaupset R, Romild U, Bonjer J (2008) Long-term outcome of laparoscopic surgery for colorectal cancer: a Cochrane systematic review of randomised controlled trials. Cancer Treat Rev 34:498–504PubMedCrossRefGoogle Scholar
  2. 2.
    Ziogas D, Polychronidis A, Kanellos I, Roukos D (2009) Laparoscopic colectomy survival benefit for colon cancer: is evidence from a randomized trial true? Ann Surg 249:695–696PubMedCrossRefGoogle Scholar
  3. 3.
    Poon JT, Law WL (2009) Laparoscopic resection for rectal cancer: a review. Ann Surg Oncol 16:3038–3047PubMedCrossRefGoogle Scholar
  4. 4.
    Ziogas D, Roukos D (2008) Robotic surgery for rectal cancer: may it improve also survival? Surg Endosc 22:1405–1406PubMedCrossRefGoogle Scholar
  5. 5.
    Katsios GC, Baltogiannis G, Roukos DH (2010) Laparoscopic surgery for gastric cancer: comparative-effectiveness research and future trends. Expert Rev Anticancer Ther 10(4):473–476PubMedCrossRefGoogle Scholar
  6. 6.
    Liakakos T, Roukos DH (2009) Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes. Ann Surg 250:349–350PubMedCrossRefGoogle Scholar
  7. 7.
    Liakakos T, Roukos D (2008) Laparoscopic gastrectomy: advances enable wide clinical application. Surg Endosc 22:1553–1555PubMedCrossRefGoogle Scholar
  8. 8.
    Roukos DH (2009) Laparoscopic gastrectomy and personal genomics: high-volume surgeons and predictive biomedicine may govern the future for resectable gastric cancer. Ann Surg 250:650PubMedCrossRefGoogle Scholar
  9. 9.
    Liakakos T, Roukos DH (2008) Is there any long-term benefit in quality of life after laparoscopy-assisted distal gastrectomy for gastric cancer? Surg Endosc 22:1402–1404PubMedCrossRefGoogle Scholar
  10. 10.
    McKenzie S, Baek JH, Wakabayashi M, Garcia-Aguilar J, Pigazzi A (2010) Totally laparoscopic right colectomy with transvaginal specimen extraction: the authors’ initial institutional experience. Surg Endosc 24:2048–2052PubMedCrossRefGoogle Scholar
  11. 11.
    Roukos DH (2010) Systems medicine: a real approach for future personalized oncology? Pharmacogenomics 11:283–287PubMedCrossRefGoogle Scholar
  12. 12.
    Roukos DH, Katsios C, Liakakos T (2010) Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn 10:541–545PubMedCrossRefGoogle Scholar
  13. 13.
    Roukos DH (2009) Isolated tumor cells in breast cancer. N Engl J Med 361:1994–1995PubMedCrossRefGoogle Scholar
  14. 14.
    Roukos DH, Tzakos A, Zografos G (2009) Current concerns and challenges towards tailored anti-angiogenic therapy in cancer. Expert Rev Anticancer Ther 9:1413–1416PubMedCrossRefGoogle Scholar
  15. 15.
    Roukos DH (2009) Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg 249:1067–1068PubMedCrossRefGoogle Scholar
  16. 16.
    Ziogas D, Roukos DH (2009) Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol 16:1771–1782PubMedCrossRefGoogle Scholar
  17. 17.
    Roukos DH (2010) Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance. Ann Surg Oncol 17:14–17PubMedCrossRefGoogle Scholar
  18. 18.
    Ziogas D, Roukos DH (2009) CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer? Ann Surg Oncol 16:2678–2681PubMedCrossRefGoogle Scholar
  19. 19.
    Roukos DH, Ziogas D (2010) From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev Anticancer Ther 10:123–128PubMedCrossRefGoogle Scholar
  20. 20.
    Roukos DH (2010) Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn 10:33–48PubMedCrossRefGoogle Scholar
  21. 21.
    Roukos DH (2010) Cancer genome explosion and systems biology: impact on surgical oncology? Ann Surg Oncol. doi:10.1245/s10434-010-1355-y
  22. 22.
    Katsios C, Ziogas DE, Roukos DH (2010) Colorectal cancer: cetuximab, KRAS, BRAF, PIK3CA mutations and beyond. Expert Rev Gastroenterol Hepatol 4(5):525–529PubMedCrossRefGoogle Scholar
  23. 23.
    Roukos DH (2010) Beyond next-generation genome sequencing technology: epigenome, dynamic systems and medical implications. Expert Rev Med Devices. doi:10.1586/ERD.10.68
  24. 24.
    Roukos DH, Ziogas DE, Katsios C (2010) Multigene assays and isolated tumor cells for early breast cancer treatment: time for bionetworks. Expert Rev Anticancer Ther 10(8):1187–1195PubMedGoogle Scholar
  25. 25.
    Roukos DH (2010) Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics 11(8):1039–1043PubMedCrossRefGoogle Scholar
  26. 26.
    Roukos DH (2010) Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice. Biomark Med 4(4):583–586PubMedCrossRefGoogle Scholar
  27. 27.
    Katsios C, Roukos DH (2010) Individual genomes and personalized medicine: life diversity and complexity. Per Med 7(4):347–350CrossRefGoogle Scholar
  28. 28.
    Roukos DH (2010) Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 10(3):247–250PubMedCrossRefGoogle Scholar
  29. 29.
    Roukos DH (2009) Radiation therapy for breast cancer. N Engl J Med 360(13):1362; author reply 1363PubMedCrossRefGoogle Scholar
  30. 30.
    Roukos DH, Lykoudis E, Liakakos T (2008) Genomics and challenges toward personalized breast cancer local control. J Clin Oncol 26(26):4360–4361PubMedCrossRefGoogle Scholar
  31. 31.
    Roukos DH, Ziogas D (2009) Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the great for the "Gordian knot"? Ann Surg Oncol 16(3):774–775PubMedCrossRefGoogle Scholar
  32. 32.
    Roukos DH (2009) Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer. Ann Surg Oncol 16(4):795–798PubMedCrossRefGoogle Scholar
  33. 33.
    Roukos DH (2009) Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn 9(1):1–6PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Chirurgische KlinikSt. ElisabethenkrankenhausFrankfurtGermany

Personalised recommendations